Rockwell Medical (NASDAQ:RMTI) Raised to Buy at StockNews.com

Rockwell Medical (NASDAQ:RMTI) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Thursday.

RMTI has been the subject of a number of other research reports. HC Wainwright decreased their target price on Rockwell Medical from $9.00 to $7.00 and set a “buy” rating for the company in a research report on Monday, November 25th. RODMAN&RENSHAW raised Rockwell Medical to a “strong-buy” rating in a research report on Thursday, November 14th. Finally, Rodman & Renshaw initiated coverage on Rockwell Medical in a research report on Thursday, November 14th. They issued a “buy” rating and a $5.00 target price for the company.

Rockwell Medical Price Performance

Shares of NASDAQ:RMTI opened at $2.04 on Thursday. Rockwell Medical has a fifty-two week low of $1.16 and a fifty-two week high of $5.15. The business has a 50-day simple moving average of $3.06 and a two-hundred day simple moving average of $2.68. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.41. The firm has a market cap of $65.93 million, a price-to-earnings ratio of -40.80 and a beta of 1.38.

Institutional Investors Weigh In On Rockwell Medical

Large investors have recently made changes to their positions in the company. Concurrent Investment Advisors LLC bought a new stake in shares of Rockwell Medical during the 3rd quarter valued at about $40,000. Verus Capital Partners LLC bought a new stake in shares of Rockwell Medical during the 3rd quarter valued at about $51,000. Barclays PLC bought a new stake in shares of Rockwell Medical during the 3rd quarter valued at about $90,000. Beacon Financial Advisory LLC bought a new stake in shares of Rockwell Medical during the 3rd quarter valued at about $98,000. Finally, XTX Topco Ltd grew its stake in shares of Rockwell Medical by 45.7% during the 3rd quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock valued at $113,000 after purchasing an additional 8,922 shares during the period. 23.31% of the stock is currently owned by institutional investors.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.